Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Tursz

Showing results (51-60 of 231) with videos related to

Pageof 24
Sort By:
International Journal of Immunopharmacology|January 1, 1983
Effect of a synthetic thymic factor (facteur thymique serique) on natural killer cell activity in humansM C Dokhelar, T Tursz, M Dardenne, et al.
European Journal of Immunology|May 1, 1991
CD77: an antigen of germinal center B cells entering apoptosisM Mangeney, Y Richard, D Coulaud, et al.
The EMBO Journal|January 1, 1983
Common multigenic activation in different human neoplasiasN Hanania, D Shaool, J Harel, et al.
Monographs in Allergy|January 1, 1991
CD23 and epithelial cellsG Rousselet, M Billaud, P Busson, et al.
Cancer|December 1, 1982
Low natural killer cell activity in patients with malignant lymphomaT Tursz, M C Dokhelar, M Lipinski, et al.
International Journal of Cancer|October 15, 1985
Induction of cell differentiation in Burkitt lymphoma lines. BLA: a glycolipid marker of B-cell differentiationA Balana, J Wiels, C Tetaud, et al.
Molecular Immunology|April 1, 1995
The fate of human CD77+ germinal center B lymphocytes after rescue from apoptosisM Mangeney, G Rousselet, S Taga, et al.
Cancer Genetics and Cytogenetics|March 1, 1993
Cytogenetic studies in three xenografted nasopharyngeal carcinomasA Bernheim, G Rousselet, L Massaad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Exosomes for cancer immunotherapyF Andre, B Escudier, E Angevin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1989
A monoclonal antibody recognizing 68- to 75-kilodalton protein(s) associated with the human IL-1 receptorC Bensimon, H Wakasugi, N Wakasugi, et al.
Pageof 24

Showing results (51-60 of 231) with videos related to

Sort By:
Pageof 24
International Journal of Immunopharmacology|January 1, 1983
Effect of a synthetic thymic factor (facteur thymique serique) on natural killer cell activity in humansM C Dokhelar, T Tursz, M Dardenne, et al.
European Journal of Immunology|May 1, 1991
CD77: an antigen of germinal center B cells entering apoptosisM Mangeney, Y Richard, D Coulaud, et al.
The EMBO Journal|January 1, 1983
Common multigenic activation in different human neoplasiasN Hanania, D Shaool, J Harel, et al.
Monographs in Allergy|January 1, 1991
CD23 and epithelial cellsG Rousselet, M Billaud, P Busson, et al.
Cancer|December 1, 1982
Low natural killer cell activity in patients with malignant lymphomaT Tursz, M C Dokhelar, M Lipinski, et al.
International Journal of Cancer|October 15, 1985
Induction of cell differentiation in Burkitt lymphoma lines. BLA: a glycolipid marker of B-cell differentiationA Balana, J Wiels, C Tetaud, et al.
Molecular Immunology|April 1, 1995
The fate of human CD77+ germinal center B lymphocytes after rescue from apoptosisM Mangeney, G Rousselet, S Taga, et al.
Cancer Genetics and Cytogenetics|March 1, 1993
Cytogenetic studies in three xenografted nasopharyngeal carcinomasA Bernheim, G Rousselet, L Massaad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Exosomes for cancer immunotherapyF Andre, B Escudier, E Angevin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1989
A monoclonal antibody recognizing 68- to 75-kilodalton protein(s) associated with the human IL-1 receptorC Bensimon, H Wakasugi, N Wakasugi, et al.
Pageof 24